Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression

被引:74
作者
Yamagishi, S
Takeuchi, M
Matsui, T
Nakamura, K
Imaizumi, T
Inoue, H
机构
[1] Kurume Univ, Sch Med, Dept Internal Med 3, Kurume, Fukuoka 8300011, Japan
[2] Hokuriku Univ, Fac Pharmaceut Sci, Dept Pathophysiol Sci, Kanazawa, Ishikawa 9201181, Japan
[3] Kurume Univ, Sch Med, Radioisotope Inst Basic & Clin Med, Kurume, Fukuoka 8300011, Japan
关键词
advanced glycation end products; angiotensin II; diabetic retinopathy; oxidative stress; pericyte loss; receptor for AGEs;
D O I
10.1016/j.febslet.2005.06.058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Advanced glycation end product (AGE)-their receptor (RAGE) and angiotensin II (AII) are implicated in diabetic retinopathy. However, a crosstalk between the two is not fully understood. In vivo, AGE injection stimulated RAGE expression in the eye of spontaneously hypertensive rats, which was blocked by an AII-type 1 receptor blocker, telmisartan. In vitro, AII-type 1 receptor-mediated reactive oxygen species generation elicited RAGE gene expression in pericytes through NF-kappa B activation. Further, AII augmented AGE-induced pericyte apoptosis, the earliest hallmark of diabetic retinopathy. Our present study may implicate a crosstalk between AGE-RAGE system and AII in diabetic retinopathy. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4265 / 4270
页数:6
相关论文
共 41 条
  • [1] Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes
    Amano, S
    Yamagishi, S
    Inagaki, Y
    Nakamura, K
    Takeuchi, M
    Inoue, H
    Imaizumi, T
    [J]. MICROVASCULAR RESEARCH, 2005, 69 (1-2) : 45 - 55
  • [2] Anderson S, 1997, KIDNEY INT, pS107
  • [3] AN ACTIVATED FORM OF TRANSFORMING GROWTH FACTOR-BETA IS PRODUCED BY COCULTURES OF ENDOTHELIAL-CELLS AND PERICYTES
    ANTONELLIORLIDGE, A
    SAUNDERS, KB
    SMITH, SR
    DAMORE, PA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) : 4544 - 4548
  • [4] Benefits of blood pressure reduction in diabetic patients
    Ball, SG
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 : S31 - S36
  • [5] AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
    Bierhaus, A
    Hofmann, MA
    Ziegler, R
    Nawroth, PP
    [J]. CARDIOVASCULAR RESEARCH, 1998, 37 (03) : 586 - 600
  • [6] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [7] Angiotensin receptors in cardiac and renal hypertrophy in rats
    Brown, L
    Passmore, M
    Duce, B
    Sernia, C
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (11) : 2925 - 2929
  • [8] Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
    Chaturvedi, N
    Sjolie, AK
    Stephenson, JM
    Abrahamian, H
    Keipes, M
    Castellarin, A
    Rogulja-Pepeonik, Z
    Fuller, JH
    [J]. LANCET, 1998, 351 (9095) : 28 - 31
  • [9] RETINAL VASCULAR PATTERNS .4. DIABETIC RETINOPATHY
    COGAN, DG
    KUWABARA, T
    TOUSSAINT, D
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1961, 66 (03) : 366 - &
  • [10] The role of the renin-angiotensin-aidosterone system in diabetes and its vascular complications
    Cooper, ME
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (11) : 16S - 20S